AngioDynamics, Inc. (ANGO)
12.36
+0.34
(+2.87%)
USD |
NASDAQ |
Oct 23, 16:00
12.37
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Total Assets (Quarterly) : 241.93M for Aug. 31, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 241.93M |
| May 31, 2026 | 267.16M |
| February 28, 2026 | 260.68M |
| November 30, 2025 | 269.68M |
| August 31, 2025 | 265.64M |
| May 31, 2025 | 280.14M |
| February 28, 2025 | 285.42M |
| November 30, 2024 | 291.55M |
| August 31, 2024 | 293.63M |
| May 31, 2024 | 317.67M |
| February 29, 2024 | 324.84M |
| November 30, 2023 | 499.62M |
| August 31, 2023 | 493.95M |
| May 31, 2023 | 532.64M |
| February 28, 2023 | 542.85M |
| November 30, 2022 | 558.21M |
| August 31, 2022 | 557.65M |
| May 31, 2022 | 552.75M |
| February 28, 2022 | 543.18M |
| November 30, 2021 | 554.10M |
| August 31, 2021 | 555.76M |
| May 31, 2021 | 561.44M |
| February 28, 2021 | 582.24M |
| November 30, 2020 | 588.52M |
| August 31, 2020 | 583.76M |
| Date | Value |
|---|---|
| May 31, 2020 | 594.21M |
| February 29, 2020 | 731.96M |
| November 30, 2019 | 724.88M |
| August 31, 2019 | 690.36M |
| May 31, 2019 | 836.44M |
| February 28, 2019 | 777.80M |
| November 30, 2018 | 783.96M |
| August 31, 2018 | 693.87M |
| May 31, 2018 | 705.47M |
| February 28, 2018 | 698.43M |
| November 30, 2017 | 697.81M |
| August 31, 2017 | 700.34M |
| May 31, 2017 | 707.96M |
| February 28, 2017 | 704.32M |
| November 30, 2016 | 712.17M |
| August 31, 2016 | 726.71M |
| May 31, 2016 | 726.19M |
| February 29, 2016 | 753.51M |
| November 30, 2015 | 760.37M |
| August 31, 2015 | 771.79M |
| May 31, 2015 | 773.62M |
| February 28, 2015 | 783.14M |
| November 30, 2014 | 799.33M |
| August 31, 2014 | 796.11M |
| May 31, 2014 | 798.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 45.22B |
| Globus Medical, Inc. | 5.488B |
| Penumbra, Inc. | 1.975B |
| Abbott Laboratories | -- |
| Alphatec Holdings, Inc. | 791.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 77.97M |
| Shareholders Equity (Quarterly) | 163.96M |
| Debt to Equity Ratio | 0.0655 |
| Current Ratio | 2.396 |
| Net Debt Paydown Yield | -0.20% |